We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Understanding the Anthrax Threat

By HospiMedica staff writers
Posted on 15 Aug 2007
A new study reveals how anthrax-causing bacteria survive and grow inside unwitting immune cells during the crucial first moments of anthrax infection. More...


Researchers at the University of Michigan Medical School (Ann Arbor, USA) conducted mouse studies using DNA microarray technology, and were able to track which genes and enzymes play key roles during the bacterium's infiltration into macrophages, the immune system's first-responder cells in the lungs. The researchers were able to profile all the significant genetic activities in the microbe at several points in time as it invaded the macrophage, germinated, killed its host, and then escaped to spread further. Among a large number of genes shown to be highly active, the scientists picked one to study further, a previously uncharacterized gene in the MarR family that possibly regulates transcription. When they infected mouse cells with a Bacillus anthracis strain altered to lack the gene, they found the bacteria were significantly less able to cause disease.

The researchers also identified several pathways and functions that helped the microbe survive and thrive, which could be targets for future drugs. The next step will be to screen compounds that could potentially block the action of this gene and other genes identified in the study. The study appears in the July 2007 issue of the journal Infection and Immunity.

"Somehow the bacterium avoids being killed and actually hijacks these phagocytes [microbe-killing cells],” said lead author Nicholas H. Bergman, Ph.D., a research assistant professor of Bioinformatics. "New drugs should target the bug during the brief window of vulnerability, when the bacteria transform from dormant spores into active, growing organisms. That chance exists for a few hours when the invaders are inside immune cells in the lung and then pass from the lungs to the lymph nodes.”

Anthrax is an acute infectious disease and is highly lethal in some forms. Anthrax is one of only few bacteria that can form long-lived spores. Anthrax, most commonly occurs in wild and domestic grass eating mammals, can also be caught by humans when they are exposed to dead infected animals, and can also and used as a biologic weapon. The word anthrax is derived from the Greek word anthrakis, or "coal,” in reference to the black skin lesions its victims develop in a cutaneous infection.


Related Links:
University of Michigan Medical School

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.